文献速递主动脉疾病颈动脉与弓上血管

开窗/分支术者改良腔内移植物治疗累及迷走锁骨下动脉的主动脉病变

Fenestrated/Branched Physician-Modified Endovascular Grafts for Aortic Pathologies Involving the Aberrant Subclavian Artery.
PubMed 文献 · J Endovasc Ther · 2025-02-21

本文报告3例累及迷走锁骨下动脉(ASA)的主动脉病变,采用开窗/分支术者改良腔内移植物(PMEG)治疗。2例为迷走右锁骨下动脉(ARSA),其中1例自发性主动脉夹层、1例心肌梗死腔内干预后医源性夹层;第3例为迷走左锁骨下动脉(ALSA)合并Kommerell憩室(KD)起源于右位主动脉弓并发生主动脉夹层。3例均成功手术,6个月随访无事件。作者认为该方案可行且创伤较小,但需进一步研究和长期随访验证。

要点

  • 3例累及迷走锁骨下动脉的主动脉病变均采用开窗/分支PMEG完成全腔内治疗。
  • 2例为迷走右锁骨下动脉,1例为迷走左锁骨下动脉合并Kommerell憩室及右位主动脉弓。
  • 全部手术成功,6个月随访无事件,作者认为可行且创伤较小。

核心结论

  • 作者认为开窗/分支PMEG治疗累及迷走锁骨下动脉的主动脉病变可行且创伤较小,结果有前景,但需进一步研究和长期随访验证其耐久性。

研究设计与样本

  • 病例系列,共3例累及迷走锁骨下动脉的主动脉病变患者。

主要发现

  • 2例为迷走右锁骨下动脉,分别发生自发性主动脉夹层和心肌梗死腔内干预后医源性主动脉夹层。
  • 第3例为迷走左锁骨下动脉合并Kommerell憩室,起源于右位主动脉弓,发生主动脉夹层。
  • 3例均使用Ankura胸主动脉腔内移植物(Lifetech,深圳,中国)在台下改良,分别为双侧锁骨下动脉添加内分支和开窗。
  • 全部手术成功,全部患者完成6个月随访且无事件。

临床怎么用

  • 作者认为PMEG可用于迷走锁骨下动脉患者主动脉病变的全腔内治疗,可行且有效,可能有助于简化复杂主动脉病变的治疗。

局限性

  • 原文指出需进一步研究和长期随访以完善该技术方法并验证其耐久性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The case series aim to explore the feasibility and effectiveness of using fenestrated/branched physician-modified endovascular grafts (PMEGs) to treat aortic pathologies involving the aberrant subclavian artery (ASA). TECHNIQUE: We presented 3 cases with multiple anomalies and complications related to the ASA. Two patients had aberrant right subclavian arteries (ARSA) and developed aortic dissection spontaneously or iatrogenically after endovascular intervention for myocardial infarction. The third patient had an aberrant left subclavian artery (ALSA) together with a Kommerell's diverticulum (KD) arising from a right-sided aortic arch and developed an aortic dissection. In all 3 cases, an Ankura thoracic endograft (Lifetech, Shenzhen, China) was back-table modified by adding an inner branch and a fenestration for bilateral subclavian arteries, respectively. All procedures were successfully conducted, and all patients underwent 6-month follow-up courses, which were uneventful. CONCLUSION: Our case series demonstrate a feasible and less invasive therapeutic approach, which produces promising results in treating the aortic pathologies involving the ASA. Further studies and long-term follow-up are required to refine this technical approach and to validate its durability. CLINICAL IMPACT: The case series illustrate a total endovascular approach to treat aortic arch pathologies involving the ASA, which is one of the most frequent aortic arch anomalies. The use of PMEGs allows meticulous subclavian artery reconstruction without significant trauma brought by traditional open or hybrid approach. Our cases suggest that using PMEGs for total endovascular management of patients with ASA is feasible and effective, and it may help streamline the treatment of complex aortic pathologies.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Yu L, Jiang X, Qiao G, et al. Fenestrated/Branched Physician-Modified Endovascular Grafts for Aortic Pathologies Involving the Aberrant Subclavian Artery. J Endovasc Ther. 2025. PMID: 39981955. doi:10.1177/15266028251320513

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。